Kestra Medical Technologies Ltd has a consensus price target of $27.2 based on the ratings of 5 analysts. The high is $29 issued by Wolfe Research on March 31, 2025. The low is $24 issued by Goldman Sachs on March 31, 2025. The 3 most-recent analyst ratings were released by Wolfe Research, Wells Fargo, and Stifel on March 31, 2025, respectively. With an average price target of $28.33 between Wolfe Research, Wells Fargo, and Stifel, there's an implied 18.92% upside for Kestra Medical Technologies Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/31/2025 | Buy Now | 21.72% | Wolfe Research | Mike Polark54% | → $29 | Initiates | → Outperform | Get Alert |
03/31/2025 | Buy Now | 17.52% | Wells Fargo | Larry Biegelsen67% | → $28 | Initiates | → Overweight | Get Alert |
03/31/2025 | Buy Now | 17.52% | Stifel | Rick Wise73% | → $28 | Initiates | → Buy | Get Alert |
03/31/2025 | Buy Now | 0.73% | Goldman Sachs | David Roman35% | → $24 | Initiates | → Neutral | Get Alert |
03/31/2025 | Buy Now | 13.33% | Piper Sandler | Matt O'Brien49% | → $27 | Initiates | → Overweight | Get Alert |
The latest price target for Kestra Medical Techs (NASDAQ:KMTS) was reported by Wolfe Research on March 31, 2025. The analyst firm set a price target for $29.00 expecting KMTS to rise to within 12 months (a possible 21.72% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Kestra Medical Techs (NASDAQ:KMTS) was provided by Wolfe Research, and Kestra Medical Techs initiated their outperform rating.
There is no last upgrade for Kestra Medical Techs
There is no last downgrade for Kestra Medical Techs.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kestra Medical Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kestra Medical Techs was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.
While ratings are subjective and will change, the latest Kestra Medical Techs (KMTS) rating was a initiated with a price target of $0.00 to $29.00. The current price Kestra Medical Techs (KMTS) is trading at is $23.83, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.